SCHEMBL9869323

SCHEMBL9869323

OC(COCc1ccccn1)CN1CCCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.70
WDR77 Q9BQA1 1/20 0.70
KDM4E B2RXH2 1/20 0.56
TSHR P16473 3/20 0.55
CYP2D6 P10635 2/20 0.55
HIF1A Q16665 1/20 0.55
GAA P10253 3/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPK1 P28482 3/20 0.53
HTT P42858 2/20 0.53
ATM Q13315 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 2/20 0.51
HSD17B10 Q99714 1/20 0.51
ACE2 Q9BYF1 1/20 0.50
CYP2C19 P33261 1/20 0.50
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
USP2 O75604 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9869970 0.84 PRMT5 (0.51) PRMT5WDR77KDM4ETSHRCYP2D6
SCHEMBL15833543 0.83 PRMT5 (1.00) PRMT5WDR77SMN1; SMN2KMT2A
SCHEMBL7047201 0.80 CYP2D6 (0.52) PRMT5WDR77KDM4ETSHRCYP2D6
SCHEMBL9839972 0.79 TSHR (0.74) PRMT5WDR77KDM4ETSHRCYP2D6
SCHEMBL9838876 0.79 TSHR (0.74) PRMT5WDR77KDM4ETSHRCYP2D6
SCHEMBL9838885 0.79 TSHR (0.74) PRMT5WDR77KDM4ETSHRCYP2D6
SCHEMBL30972154 0.76 LTA4H (0.54)
SCHEMBL30972142 0.74 LTA4H (0.52) TSHR
SCHEMBL25010831 0.72 KDM4E (1.00) KDM4ETSHRCYP2D6HIF1AMAPK1
SCHEMBL11537591 0.72 KDM4E (1.00) KDM4ETSHRCYP2D6HIF1AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4999361-A Cardiovascular disorders, blood vessel relaxants BOEHRINGER MANNHEIM GMBH (DE) 1991-03-12 US disclosed
EP-0330940-A2 Trisubstituted amines, process for their preparation and pharmaceutical preparations containing these compounds Roche Diagnostics GmbH (DE) 1989-09-06 EP disclosed